Endogenous opioid peptides mediate the effect of suckling on LH and PRL in the domestic pig. However, the role of opioids in modulating GH during lactation in swine is not known. Primiparous sows that had been immunized against GRF(1-29) conjugated to human serum albumin (GRF-HSA, n=5) or HSA (n=4) were used to determine changes in GH after naloxone. Treatments were imposed in all sows on day 21 of lactation when antibody titers were 9100 ± 1629. All sows received (LV.) naloxone (0.25 mgfkg) or saline (0.0125 mlfkg) at 15 min intervals for 165 min. Active immunization against GRF-HSAduring lactation decreased (P < 0.05) mean concentration (4.8 ± 0.2 vs 2.6 ± 0.1 ng/ml) and frequency (1.5 ± 0.3 vs 0.4 ± 0.2 peaks/4 hr).
INTRODUCTION
During lactation, suckling by piglets causes PRL to be elevated and LH release to be suppressed, effects which are mediated through endogenous opioid peptides (1) (2) (3) (4) (5) . Infusion or single injection of the opioid antagonist naloxone increased LH (2, 4, 5) and decreased PRL (2, 5) . Administration of morphine prevented the rise in LH induced by transient removal of the litter (cessation of suckling, 3). Growth hormone is lactogenic in mammals, but less is known about control of GH during lactation in the pig. Naloxone decreased GH in lactating sows (6) and in rodents (7) (8) (9) , but it is not clear whether this was due to an effect at the level of the hypothalamus or anterior pituitary.
We investigated the site of action of opioid peptides in modulating GH during lactation in the pig. To accomplish this we utilized lactating sows that had been actively immunized against GRF [GRF(1-29)-(GlY)4-Cys-NH21 conju gated to human serum albumin (GRF-HSA) or HSA alone (10) . This allowed differentiation of the effects of suckling on GH at the level of the hypothalamus, hypophysis or both.
Radio-labeled GRF was prepared by incubating GRF (10 ) .lg in 20 J.lI 0.6 N ammonium acetate), 1 mCi 1:l51 and 2 J.lg iodogen (1, 3, 4, 6 -tetrachloro-3 alpha, 6 alpha-diphenylglycouril) for 8.5 min. The reaction was stopped by transferring the mixture to a 30 X 0.7 cm carboxymethyl cellulose column preconditioned with ammonium acetate buffer (0.002 N; pH=7.2). Labeled GRF was eluted with increasing'concentrations of ammonium acetate (0.01 to 0.6 N).
Concentrations of GH were measured by procedures previously validated (10) using antiserum provided by A. F. Parlow (AFP 10318545). Average intra and inter-assay CV's were 5.4% and 9.7%, respectively. Luteinizing hormone was measured as previously validated (13) with modifications (14) . Intra-assay CV was 16.4%. Concentrations of PRL were quantified according to validated procedures (15) . Intra-assay CV was 13.8%.
Data for serum concentrations of LH, GH and PRL were analyzed by split plot analyses of variance (16) using general linear models (1 7). The full model utilized for GH, LH and PRL included treatment (GRF vs GRF-HSA), replicate (1 vs 2), treatment x replicate, sow within treatment x replicate, period (naloxone vs saline), period x treatment, time and two-way interactions in volving time. Effect of treatment, replicate and treatment x replicate were tested using the sow within treatment x replicate mean square as the error term; period and period x treatment were tested using the period x sow within treatment mean square as error term. Initial analyses indicated that replicate or the treatment x replicate interaction did not contribute (P > 0.5) to variation in GH; therefore, subsequent analyses did not include replicate or treatment x replicate. Split-plot analyses were then performed within treatment and within treatment and period to more clearly define the effects of naloxone and time, respectively, on GH. In order to more clearly ascertain temporal changes in GH, data were broken down into hourly periods before (-30, -15 and 0 min before injection; 0 hr) and after initial injection of naloxone or saline (1, 2, 3 and 4 hr). Models as previously described were utilized with the exception that time was replaced by hour. Hourly means were separated using Student Newman Keuls test. The treatment and period x treatment effects did not contribute to variation in LH and PRL, thus data were pooled across treatment.
An episode of GH or LH release was defined as values that exceeded a previous nadir by at least 50% and the increase had to be greater than the sensitivity of the assay. Basal GH was defined as the mean of all samples during a sampling period excluding those associated with episodic release of GH. Frequency of release and basal GH were analyzed by one way analyses of variance using a model that included treatment (GRF vs GRF-HSA), period (naloxone vs saline) and period x treatment.
RESULTS
Antibody titers against GRF on day 109 of gestation and day 21 of lactation were 12,000 + 2,832 and 9,100 ± 1,629, respectively. Titers ranged from 2,000 to 16,000 in GRF-HSA gilts on day 21. Serum for HSA pigs bound <10% at 1:100.
Characteristics of GH secretion in lactating sows immunized against GRF HSA or HSA and administered naloxone or vehicle (saline) are in Table 1 . Average GH from -30 to 240 min from initiation of saline is in Figure 1 . Active immunization against GRF decreased (P < 0.05) average concentrations of GH Figure 1) , by suppressing episodic release of GH (Table 1) . Im munization against GRF-HSA also decreased basal GH concentrations (Table  1) .
Changes in average GH from 0 to 4 hr from naloxone or saline in GRF-HSA and HSA immunized sows are shown in Figure 2 . Initial analysis revealed that treatment, period, hour and the period x hour interaction contributed (P < 0.01) to variation in GH. The treatment x period and treatment x hour interactions were not significant (P > 0.10). In GRF-HSA and HSA immunized sows, concentrations of GH were lower (P < 0.05) at 1, 2, 3 and 4 hr than at 0 hr from initial injection of naloxone; however, concentrations of GH at hours 0, 1, 2, 3 and 4 from saline were similar in all sows (Figure 2) . Episodes of GH release were not detected in any sow from 15 to 240 min after initiation of naloxone. Frequency of release of GH (Table 1) was suppressed by naloxone, but not saline, in HSA sows. Basal GH was not decreased (P > 0.10) by naloxone in HSA sows ( Table 1) . Frequency of GH release was not decreased (P > 0.10) by naloxone in GRF-HSA immunized sows; however, basal GH was decreased (P < 0.05) by naloxone, but not saline, in GRF-HSA immunized sows ( Table   1 ).
Concentrations of PRL were not altered by immuno-neutralization of GRF (data not presented). Serum concentrations of PRL from -30 to 210 min from saline or naloxone averaged across GRF-HSA and HSA immunized gilts are depicted in Figure 3 . Naloxone resulted in a decrease in PRL at 90, 150 and 210 min after initiation of injections.
Serum LH was not altered by immunization against G RF (data not shown) nor by administration of naloxone (Figure 4) . Concentrations of LH in all sows were near the assay senSitivity (.2 ng/ml) and overall frequency of LH release averaged 0.25 ± 0.25 peaks/4 hr. Minutes from Initial Injection 
DISCUSSION
These data demonstrate that elevated concentrations of GH in the lactating pig are primarily due to an opioid modulated increase in GRF. Active immu nization against GRF abolished episodic secretion of GH, thereby lowering average blood concentration. Wehrenberg (18) demonstrated that passive im munization against G RF lowered basal and suckling-stimulated concentrations of GH in the rat. Antagonism of opioid receptors in control (HSA) sows resulted in a decrease in concentration and frequency of GH release, similar to values in saline-treated GRF-immunized sows (Figure 2 ). Other reports have dem onstrated that naloxone decreased GH in suckled rat (7-9) and pig (6). An a... effect of opioids on GH during lactation is also supported by the observation that an opioid agonist increases GH in lactating beef cows (19) . Although the primary role of opioids in mediating the effects of suckling on GH are apparently via GRF, these results demonstrate an effect on GH inde pendent of GRF. Antagonism of opioid receptors with naloxone in sows im munized against GRF resulted in a small, but significant decrease in GH ( Figure  2 ). In addition, naloxone decreased basal GH in gilts immunized against GRF HSA, but not HSA. This effect may be unique to lactation and (or) during suckling, because active immunization against GRF in cyclic gilts did not lower basal GH, while episodic release of GH was abolished (10) . The exact nature of this non-GRF dependent effect of opioids on GH cannot be determined from these data. However, hypophyseal stalk transection of the pig elevates basal GH, due to decreased amount of somatostatin reaching the pituitary (20) . Thus, suckling may alter GH by decreasing somatostatin and increasing GRF.
These results corroborate our earlier report that opioids stimulate GH in swine (10) and ruminants (21, 22) primarily through a hypothalamic mech anism. Passive immunization of rats against GRF blocked the stimulatory effect of morphine (23) , beta-endorphin (24) or FK33-824 (8, (25) (26) (27) on release of GH. Met-enkephalin fibers are located in close proximity to GRF cell bodies in the median eminence of the rat (28) and release of GH from porcine somatouopes in vitro was not affected by enkephalin analogs (29) .
Results from this experiment extend previous results (2, 5) that suckling affects PRL in sows through a mechanism that involves opioids. Others reported that agonists of opioids elevated PRL (30, 31) . Suckling caused an increase in PRL and beta-endorphin in rats (32) and sheep (33) .
Failure of naloxone to increase episodic release of LH in primiparous lactating sows conflicts with previous results that infusion of naloxone, at concentrations similar to those used in this study, increased frequency of LH release (2), or a single injection of naloxone increased LH (4,5) in lactating multiparous sows. This discrepancy is likely to be related to the fact that primiparous sows were used in this study, whereas multiparous sows were used in previous studies (2, 4, 5) . Intervals from weaning to estrus are typically longer and concentrations of LH lower in primiparous than in multiparous sows (1) . Further studies are necessary to evaluate the role of opioids in mediating the effects of suckling on LH in primiparous sows.
In summary, antagonism of opioid receptors with naloxone decreased GH in lactating primiparous sows immunized against GRF-HSA or HSA. A decrease in GH in sows with GRF immuno-neutralized indicates that a portion of the effects of suckling on GH are not dependent on GRF.
